Table 3.
Bacterial isolates | Resistance rate, N (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
SXT | AMC | TE | CIP | GEN | CRO | CZN | AMP | CAZ | CAF | |
E.coli (n = 18) | 6 (33.3) | 7 (38.8) | 18 (100) | 0 | 0 | 7 (38.8) | 10 (55.5) | 1 8 (100) | 6 (33.3) | 2 (11.1) |
K.pneumoniae (n = 7) | 3 (42.8) | 4 (57.1) | 7 (100) | 4 (57.1) | 3 (42.8) | 4 (57.1) | 7 (100) | 7 (100) | 4 (57.1) | 3 (42.8) |
A.baumannii (n = 6) | 6 (100) | 5 (83.3) | 6 (100) | 2 (33.3) | 2 (33.3) | 3 (50) | 5 (83.3) | 6 (100) | 3 (50) | 2 (33.3) |
R.orinthinolytica (n = 2) | 1 (50) | 2 (100) | 0 | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) |
Total = 33 | 16 (48.5) | 18 (54.5) | 31 (93.9) | 8 (24.2) | 7 (21.2) | 16 (48.5)) | 24 (72.7) | 33 (100) | 15 (45.5) | 9 (27.2) |
SXT Trimethoprim-Sulfamethoxazole, AMC Amoxicillin-clavulanate, TE Tetracycline, Amp Ampicillin, CIP Ciprofloxacin, GEN Gentamicin, CRO Ceftriaxone, CAZ Ceftazidam and CAF Chloramphenicol